Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol

Detalhes bibliográficos
Autor(a) principal: Moreira, Octávio Couto
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/18181
Resumo: Oropharyngeal candidiasis is a challenging fungal disease in the clinical setting of immunocompromised patients, either by their morbidity or by its difficulties in treatment. Patients with AIDS, cancer, and transplanted are among the more affected. Traditionally C. albicans is the main agent of the oropharyngeal candidoasis, but other species such as C. glabrata and C. dubliniensis often show the emergence of resistance phenomenon, especially to azole antifungals agents such as fluconazole. The antiseptic mouthwashes as well as antifungal polyene nystatin, have been recommended as auxiliary agents in reducing the bacterial and fungal load of these patients, contributing to ensure the success of antifungal therapy instituted. In the present study we evaluated the susceptibility of 30 isolates of C. glabrata sensitive to fluconazole and 30 isolates of this species, but resistant to fluconazole against the antiseptic cetylpyridinium chloride, triclosan, chlorhexidine and antifungal polyene nystatin. Assays were carried out through microdilution tests according to the methodology described in document M27-A3 (CLSI, 2008). Comparisons of minimum inhibitory concentrations (MICs) between sensitive and resistant isolates to fluconazole did not show significant differences in susceptibility. On the other hand when it was evaluated the fungicidal activity assays, the minimum fungicidal concentrations (MFCs) showed no significant differences among the CFMs for the cetylpyridinium chloride, triclosan and nystatin. However, to chlorhexidine, the group of yeast resistant to fluconazole was significantly more sensitive to the fungicidal concentrations of antiseptic than fluconazole-sensitive group. The authors discuss these findings, proposing that new approaches must be taken, especially involving isolates of C. glabrata resistant to echinocandins and C. glabrata ability to develop resistance to antiseptics own. Studies evolving C. glabrata biofilms should also be assessed.
id UFSM_85966c685444e9fa78a090c1d165c7d3
oai_identifier_str oai:repositorio.ufsm.br:1/18181
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazolIn vitro antimicrobial activity in oral hollow on Candida glabrata sensitive and resistant fluconazolCandida glabrataResistência antifúngicaAntimicrobianosEnxaguatórios bucaisAntifungal resistanceAntimicrobialsOral rinsesCNPQ::CIENCIAS DA SAUDE::FARMACIAOropharyngeal candidiasis is a challenging fungal disease in the clinical setting of immunocompromised patients, either by their morbidity or by its difficulties in treatment. Patients with AIDS, cancer, and transplanted are among the more affected. Traditionally C. albicans is the main agent of the oropharyngeal candidoasis, but other species such as C. glabrata and C. dubliniensis often show the emergence of resistance phenomenon, especially to azole antifungals agents such as fluconazole. The antiseptic mouthwashes as well as antifungal polyene nystatin, have been recommended as auxiliary agents in reducing the bacterial and fungal load of these patients, contributing to ensure the success of antifungal therapy instituted. In the present study we evaluated the susceptibility of 30 isolates of C. glabrata sensitive to fluconazole and 30 isolates of this species, but resistant to fluconazole against the antiseptic cetylpyridinium chloride, triclosan, chlorhexidine and antifungal polyene nystatin. Assays were carried out through microdilution tests according to the methodology described in document M27-A3 (CLSI, 2008). Comparisons of minimum inhibitory concentrations (MICs) between sensitive and resistant isolates to fluconazole did not show significant differences in susceptibility. On the other hand when it was evaluated the fungicidal activity assays, the minimum fungicidal concentrations (MFCs) showed no significant differences among the CFMs for the cetylpyridinium chloride, triclosan and nystatin. However, to chlorhexidine, the group of yeast resistant to fluconazole was significantly more sensitive to the fungicidal concentrations of antiseptic than fluconazole-sensitive group. The authors discuss these findings, proposing that new approaches must be taken, especially involving isolates of C. glabrata resistant to echinocandins and C. glabrata ability to develop resistance to antiseptics own. Studies evolving C. glabrata biofilms should also be assessed.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESAs candidíases da orofaringe revelam-se desafiadoras no contexto clínico dos pacientes imunocomprometidos, quer pela sua morbidade, quer pelas dificuldades no tratamento. Pacientes com AIDS, com câncer, transplantados estão entre os mais atingidos. Tradicionalmente C. albicans é o principal agente, todavia outras espécies como C. glabrata e C. dubliniensis manifestam, com frequência, a emergência do fenômeno da resistência, sobretudo aos antifúngicos azólicos como o fluconazol. Os antissépticos bucais assim como o antifúngico poliênico nistatina, têm sido recomendados como agentes auxiliares na redução da carga bacteriana e fúngica destes pacientes, concorrendo para assegurar o sucesso da terapêutica antifúngica instituída. No presente estudo avaliou-se a suscetibilidade de trinta isolados de C. glabrata sensíveis ao fluconazol e trinta isolados resistentes ao fluconazol, frente aos antissépticos cloreto de cetilpiridínio, triclosan, clorhexidina e ao antifúngico poliênico nistatina. Os ensaios foram realizados através de testes de microdiluição em caldo, de acordo com metodologia descrita no documento M27-A3 (CLSI, 2008). A verificação das concentrações inibitórias mínimas destes compostos frente aos isolados sensíveis e resistentes ao fluconazol não evidenciou diferenças significativas na suscetibilidade entre os dois grupos. Quando avaliou-se a de atividade fungicida, foram evidenciadas diferenças significativas entre as concentrações fungicidas mínimas de cloreto de cetilpiridínio, triclosan e a nistatina. No entanto, frente à clorhexidina, o grupo de leveduras resistente ao fluconazol foi mais sensível do que o grupo fluconazol-sensível. Os autores discutem estes achados, propondo que novas abordagens devem ser realizadas, sobretudo envolvendo isolados de C. glabrata resistentes às equinocandinas bem como a capacidade de C. glabrata desenvolver resistência aos próprios antissépticos. Estudos envolvendo biofilmes de C. glabrata deverão também ser avaliados.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da SaúdeAlves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Peres, Paulo Edelvar Corrêahttp://lattes.cnpq.br/1363957298527005Loreto, Érico Silva dehttp://lattes.cnpq.br/5475233864057995Moreira, Octávio Couto2019-09-10T17:54:02Z2019-09-10T17:54:02Z2016-03-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/18181porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-04-25T15:17:43Zoai:repositorio.ufsm.br:1/18181Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-04-25T15:17:43Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
In vitro antimicrobial activity in oral hollow on Candida glabrata sensitive and resistant fluconazol
title Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
spellingShingle Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
Moreira, Octávio Couto
Candida glabrata
Resistência antifúngica
Antimicrobianos
Enxaguatórios bucais
Antifungal resistance
Antimicrobials
Oral rinses
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
title_full Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
title_fullStr Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
title_full_unstemmed Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
title_sort Avaliação in vitro da atividade de antimicrobianos na cavidade bucal sobre Candida glabrata sensíveis e resistentes ao fluconazol
author Moreira, Octávio Couto
author_facet Moreira, Octávio Couto
author_role author
dc.contributor.none.fl_str_mv Alves, Sydney Hartz
http://lattes.cnpq.br/0330782478769631
Peres, Paulo Edelvar Corrêa
http://lattes.cnpq.br/1363957298527005
Loreto, Érico Silva de
http://lattes.cnpq.br/5475233864057995
dc.contributor.author.fl_str_mv Moreira, Octávio Couto
dc.subject.por.fl_str_mv Candida glabrata
Resistência antifúngica
Antimicrobianos
Enxaguatórios bucais
Antifungal resistance
Antimicrobials
Oral rinses
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Candida glabrata
Resistência antifúngica
Antimicrobianos
Enxaguatórios bucais
Antifungal resistance
Antimicrobials
Oral rinses
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Oropharyngeal candidiasis is a challenging fungal disease in the clinical setting of immunocompromised patients, either by their morbidity or by its difficulties in treatment. Patients with AIDS, cancer, and transplanted are among the more affected. Traditionally C. albicans is the main agent of the oropharyngeal candidoasis, but other species such as C. glabrata and C. dubliniensis often show the emergence of resistance phenomenon, especially to azole antifungals agents such as fluconazole. The antiseptic mouthwashes as well as antifungal polyene nystatin, have been recommended as auxiliary agents in reducing the bacterial and fungal load of these patients, contributing to ensure the success of antifungal therapy instituted. In the present study we evaluated the susceptibility of 30 isolates of C. glabrata sensitive to fluconazole and 30 isolates of this species, but resistant to fluconazole against the antiseptic cetylpyridinium chloride, triclosan, chlorhexidine and antifungal polyene nystatin. Assays were carried out through microdilution tests according to the methodology described in document M27-A3 (CLSI, 2008). Comparisons of minimum inhibitory concentrations (MICs) between sensitive and resistant isolates to fluconazole did not show significant differences in susceptibility. On the other hand when it was evaluated the fungicidal activity assays, the minimum fungicidal concentrations (MFCs) showed no significant differences among the CFMs for the cetylpyridinium chloride, triclosan and nystatin. However, to chlorhexidine, the group of yeast resistant to fluconazole was significantly more sensitive to the fungicidal concentrations of antiseptic than fluconazole-sensitive group. The authors discuss these findings, proposing that new approaches must be taken, especially involving isolates of C. glabrata resistant to echinocandins and C. glabrata ability to develop resistance to antiseptics own. Studies evolving C. glabrata biofilms should also be assessed.
publishDate 2016
dc.date.none.fl_str_mv 2016-03-21
2019-09-10T17:54:02Z
2019-09-10T17:54:02Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/18181
url http://repositorio.ufsm.br/handle/1/18181
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922137109692416